XML 35 R22.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2024
Summary of Significant Accounting Policies  
Schedule of United Kingdom research and development incentives receivable

    

Current

    

Long-Term

 

Total

Balance at December 31, 2023

 

$

23,894

$

25,468

$

49,362

UK research and development incentives, transfer

 

25,468

(25,468)

 

UK research and development incentives, adjustments

(25,468)

(20)

(25,488)

UK research and development incentives cash receipt

 

(23,848)

 

 

(23,848)

Foreign currency translation

 

(46)

 

20

 

(26)

Balance at December 31, 2024

$

$

$

Schedule of potentially dilutive outstanding instruments which were not included in the computation of diluted EPS

December 31, 

December 31, 

    

2024

    

2023

Common stock purchase warrants

1,467,581

408,640

Stock options

 

229,919

 

56,609

Convertible debt

 

360,335

 

273,973

Total

 

2,057,835

 

739,222